These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 3942594)
1. The increased cytotoxicity in colon adenocarcinoma of methotrexate-5-fluorouracil is not associated with increased induction of lesions in DNA by 5-fluorouracil. Lönn U; Lönn S Biochem Pharmacol; 1986 Jan; 35(2):177-81. PubMed ID: 3942594 [TBL] [Abstract][Full Text] [Related]
2. Azidothymidine and dipyridamole as biochemical response modifiers: synergism with methotrexate and 5-fluorouracil in human colon and pancreatic carcinoma cells. Zhen YS; Taniki T; Weber G Oncol Res; 1992; 4(2):73-8. PubMed ID: 1596584 [TBL] [Abstract][Full Text] [Related]
3. Current studies of methotrexate and 5-fluorouracil and their interaction in human tumor cells. Tattersall MH Semin Oncol; 1983 Jun; 10(2 Suppl 2):6-14. PubMed ID: 6867755 [TBL] [Abstract][Full Text] [Related]
4. Combinations of 5-FU, hypoxanthine and allopurinol in chemotherapy for human colon adenocarcinoma xenografts. Houghton JA; Houghton PJ Cancer Treat Rep; 1982 May; 66(5):1201-6. PubMed ID: 7083222 [TBL] [Abstract][Full Text] [Related]
5. Effects of folylpolyglutamate synthetase modulation on chemosensitivity of colon cancer cells to 5-fluorouracil and methotrexate. Sohn KJ; Smirnakis F; Moskovitz DN; Novakovic P; Yates Z; Lucock M; Croxford R; Kim YI Gut; 2004 Dec; 53(12):1825-31. PubMed ID: 15542523 [TBL] [Abstract][Full Text] [Related]
6. Modulation of 5-fluorouracil metabolism and cytotoxicity by antimetabolite pretreatment in human colorectal adenocarcinoma HCT-8. Benz C; Cadman E Cancer Res; 1981 Mar; 41(3):994-9. PubMed ID: 7459888 [TBL] [Abstract][Full Text] [Related]
7. Schedule-dependent cytotoxicity of methotrexate and 5-fluorouracil in human colon and breast tumor cell lines. Benz C; Schoenberg M; Choti M; Cadman E J Clin Invest; 1980 Nov; 66(5):1162-5. PubMed ID: 7430346 [TBL] [Abstract][Full Text] [Related]
8. Sequence-dependent administration of 5-fluorouracil maintains methotrexate antineoplastic activity in human estrogen-negative breast cancer and protects against methotrexate cytotoxicity in human bone marrow. Das JR; Fryar-Tita EB; Zhou Y; Green S; Southerland WM; Bowen D Anticancer Res; 2007; 27(6B):3791-9. PubMed ID: 18225534 [TBL] [Abstract][Full Text] [Related]
9. [Sequential methotrexate and 5-fluorouracil]. Sasaki T Gan To Kagaku Ryoho; 1996 Dec; 23(14):1907-10. PubMed ID: 8978795 [TBL] [Abstract][Full Text] [Related]
10. Effectiveness of intermediate-dose methotrexate and high-dose 5-fluorouracil as sequential combination chemotherapy in refractory breast cancer and as primary therapy in metastatic adenocarcinoma of the colon. Tisman G; Wu SJ Cancer Treat Rep; 1980; 64(8-9):829-35. PubMed ID: 7448820 [TBL] [Abstract][Full Text] [Related]
11. Critical modulation by thymidine and hypoxanthine of sequential methotrexate-5-fluorouracil synergism in murine L1210 cells. Piper AA; Nott SE; Mackinnon WB; Tattersall MH Cancer Res; 1983 Nov; 43(11):5101-5. PubMed ID: 6616448 [TBL] [Abstract][Full Text] [Related]
12. Azidothymidine-induced cytotoxicity and incorporation into DNA in the human colon tumor cell line HCT-8 is enhanced by methotrexate in vitro and in vivo. Tosi P; Calabresi P; Goulette FA; Renaud CA; Darnowski JW Cancer Res; 1992 Aug; 52(15):4069-73. PubMed ID: 1638518 [TBL] [Abstract][Full Text] [Related]
13. Combination therapy with methotrexate and 5-fluorouracil: a prospective randomized clinical trial of order of administration. Coates AS; Tattersall MH; Swanson C; Hedley D; Fox RM; Raghavan D J Clin Oncol; 1984 Jul; 2(7):756-61. PubMed ID: 6376719 [TBL] [Abstract][Full Text] [Related]
14. Adjuvant sequential methotrexate --> 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer. Sobrero A; Frassineti G; Falcone A; Dogliotti L; Rosso R; Di Costanzo F; Bruzzi P; Br J Cancer; 2005 Jan; 92(1):24-9. PubMed ID: 15611795 [TBL] [Abstract][Full Text] [Related]
15. Leucovorin enhances cytotoxicity of trimetrexate/fluorouracil, but not methotrexate/fluorouracil, in CCRF-CEM cells. Romanini A; Li WW; Colofiore JR; Bertino JR J Natl Cancer Inst; 1992 Jul; 84(13):1033-8. PubMed ID: 1376779 [TBL] [Abstract][Full Text] [Related]
16. Synergism and lack of cross-resistance between short-term and continuous exposure to fluorouracil in human colon adenocarcinoma cells. Sobrero AF; Aschele C; Guglielmi AP; Mori AM; Melioli GG; Rosso R; Bertino JR J Natl Cancer Inst; 1993 Dec; 85(23):1937-44. PubMed ID: 8230285 [TBL] [Abstract][Full Text] [Related]
17. [Two cases of gastrointestinal cancers with major responses to sequential methotrexate 5-FU plus 5'-DFUR]. Tamura Y; Sakata Y; Ogasawara H; Itoh T; Furukohri N; Saitoh S; Tsushima K; Baba T; Munakata A; Yoshida Y Gan To Kagaku Ryoho; 1989 May; 16(5):2109-12. PubMed ID: 2525005 [TBL] [Abstract][Full Text] [Related]
18. Effect of 5-fluorouracil on methotrexate transport and cytotoxicity in HT29 colon adenocarcinoma cells. Chen MF; Chen LT; Boyce HW Cancer Lett; 1995 Jan; 88(2):133-40. PubMed ID: 7874685 [TBL] [Abstract][Full Text] [Related]
19. [A new sequential chemotherapy of methotrexate with 5-fluorouracil against advanced colo-rectal cancer]. Fujiki T; Futatsuki K; Akazawa S; Yamamoto K; Miyazaki M; Kanda Y; Amemiya K; Uchida N; Oishi T Gan To Kagaku Ryoho; 1993 Apr; 20(5):603-9. PubMed ID: 8470917 [TBL] [Abstract][Full Text] [Related]
20. [Sequential methotrexate-5-fluorouracil (MTX-5-FU) treatment of patients with advanced gastric and colorectal cancer. Sequential Methotrexate-5-FU Study Group]. Murakami M; Ota K; Miyazaki T; Niitsu Y; Wakui A; Yokoyama M; Kanamaru R; Futatsuki K; Akazawa S; Sakai Y Gan To Kagaku Ryoho; 1987 Aug; 14(8):2482-90. PubMed ID: 3619460 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]